| 2025-08-01 | +27.9% | earnings | Seeking Alpha | IDEXX Laboratories Q2 2025 Earnings Preview |
| 2025-08-04 | +18.9% | earnings | Seeking Alpha | Idexx raises 2025 revenue outlook to $4.28B as inVue Dx placements surge and innovation momentum builds |
| 2025-08-04 | +18.9% | earnings | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Q2 2025 Earnings Call Transcript |
| 2025-08-04 | +18.9% | news | Seeking Alpha | Biggest stock movers Monday: BLDE, COMM, SPOT, ON, and more |
| 2025-08-04 | +18.9% | earnings | Seeking Alpha | IDEXX rises on upgraded guidance fueled by inVue Dx demand |
| 2025-08-04 | +18.9% | earnings | Seeking Alpha | IDEXX Laboratories Non-GAAP EPS of $3.50 beats by $0.20, revenue of $1.11B beats by $40M |
| 2025-08-04 | +18.9% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-08-04 | +18.9% | news | Yahoo Finance | IDEXX Laboratories Stock Jumps as Pet Health Care Firm Lifts Full-Year Outlook - Yahoo Finance |
| 2025-08-04 | +18.9% | earnings | Yahoo Finance | IDEXX Stock Up on Q2 Earnings & Revenue Beat, Margins Expand - Yahoo Finance |
| 2025-08-04 | +18.9% | earnings | Investor's Business Daily | How A 'Puppy Boom' Drove This Company's Beat-And-Raise - Investor's Business Daily |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX Laboratories, Inc. 2025 Q3 - Results - Earnings Call Presentation |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX outlines 9.6%–10.3% revenue growth outlook for 2025 amid robust CAG Diagnostics expansion |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX Laboratories stock pops on Q3 beats, raised outlook |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX Laboratories Non-GAAP EPS of $3.22 beats by $0.07, revenue of $1.1B beats by $30M |
| 2025-11-03 | +15.7% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-11-03 | +15.7% | news | Yahoo Finance | Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Potentially Undervalued? - Yahoo Finance |
| 2025-11-03 | +15.7% | news | Yahoo Finance | Why Idexx Laboratories Stock Surged by Almost 15% Today - Yahoo Finance |
| 2025-11-03 | +15.7% | earnings | Yahoo Finance | IDEXX Laboratories Inc (IDXX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance |
| 2025-11-03 | +15.7% | earnings | Investing.com | Earnings call transcript: IDEXX Labs Q3 2025 beats expectations, stock surges - Investing.com |
| 2025-11-03 | +15.7% | news | Investor's Business Daily | How Idexx Laboratories Business Shook Off Bears And Hit A Record - Investor's Business Daily |
| 2025-11-03 | +15.7% | earnings | Seeking Alpha | IDEXX Laboratories stock pops on Q3 beats, raised outlook (IDXX:NASDAQ) - Seeking Alpha |
| 2025-11-03 | +15.7% | news | thestreet.com | Daily Market Wrap: Top Stocks – Amazon, Cipher, and Idexx Laboratories - thestreet.com |
| 2025-11-03 | +15.7% | earnings | ChartMill | IDEXX LABORATORIES INC (NASDAQ:IDXX) Surpasses Q3 2025 Estimates and Raises Full-Year Outlook - ChartMill |
| 2025-11-03 | +15.7% | news | StocksToTrade | IDEXX Laboratories’ Stock Soars: Growth or Bubble? - StocksToTrade |
| 2025-10-31 | +14.5% | earnings | Seeking Alpha | IDEXX upgraded to buy at Stifel on Dx analyzer recurring revenue growth |
| 2022-05-04 | -11.0% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-02-03 | +10.2% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2024-02-05 | +7.6% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2021-11-02 | -7.1% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-05-01 | +6.9% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2022-11-01 | +6.5% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2022-02-02 | +6.4% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2024-10-31 | -5.9% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-01-30 | -5.7% | earnings | Seeking Alpha | IDEXX Laboratories Q4 2025 Earnings Preview |
| 2026-04-09 | -5.4% | earnings | MarketBeat | IDEXX Laboratories, Inc. $IDXX Shares Acquired by Franklin Street Advisors Inc. NC - MarketBeat |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | Idexx targets $4.632B–$4.720B revenue for 2026 as innovation drives 8%–10% CAG diagnostics growth |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | IDEXX falls 4% following in-line 2026 guidance |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | IDEXX Laboratories, Inc. 2025 Q4 - Results - Earnings Call Presentation |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | IDEXX Laboratories Non-GAAP EPS of $3.01 beats by $0.07, revenue of $1.09B beats by $20M |
| 2026-02-02 | -5.3% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-02-02 | -5.3% | earnings | Yahoo Finance | IDEXX Stock Down Despite Q4 Earnings & Revenue Beat, Margins Rise - Yahoo Finance |
| 2026-02-02 | -5.3% | news | Investor's Business Daily | Pet Stock Dives As Investors Await The 'Puppy Boom' Patients - Investor's Business Daily |
| 2026-02-02 | -5.3% | earnings | ChartMill | IDEXX LABORATORIES INC (NASDAQ:IDXX) Reports Strong Q4 2025 Earnings Beat, Issues Cautious 2026 Outlook - ChartMill |
| 2026-02-02 | -5.3% | news | Benzinga | Why Is IDEXX Labs Stock Falling Today? - Benzinga |
| 2026-02-02 | -5.3% | earnings | Seeking Alpha | IDEXX falls 4% following in-line 2026 guidance - Seeking Alpha |
| 2026-02-02 | -5.3% | earnings | Investing.com | Earnings call transcript: IDEXX Labs Q4 2025 misses EPS, stock dips - Investing.com |
| 2026-01-31 | -5.1% | news | Yahoo Finance | IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook - Yahoo Finance |
| 2026-01-31 | -5.1% | news | Finviz | IDEXX Laboratories, Inc. (IDXX): Innovation and Seamless Leadership Transition Drive 2026 Outlook - Finviz |
| 2023-08-01 | -4.7% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-11-20 | +4.7% | news | Yahoo Finance | Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance |
| 2023-02-06 | +4.5% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2024-05-01 | -4.0% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2025-11-19 | +4.0% | analyst | MarketWatch | IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-02-04 | +3.5% | news | Seeking Alpha | IDEXX: A Great Business Trapped By A Demanding Valuation |
| 2026-02-04 | +3.5% | news | Seeking Alpha | IDEXX: A Great Business Trapped By A Demanding Valuation (NASDAQ:IDXX) - Seeking Alpha |
| 2026-04-15 | -3.5% | analyst | 24/7 Wall St. | Citi Just Made Zoetis Its Top Pick With a Buy Rating: Is the Pet Economy Boom the Best Trade of 2026? |
| 2026-04-15 | -3.5% | analyst | The Fly | Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls |
| 2026-04-15 | -3.5% | news | Zacks | Why Investors Need to Take Advantage of These 2 Medical Stocks Now |
| 2026-04-15 | -3.5% | analyst | MT Newswires | Citigroup Initiates IDEXX Laboratories at Neutral With $650 Price Target |
| 2026-04-15 | -3.5% | news | MSN | Citigroup initiates coverage of IDEXX Laboratories (IDXX) with neutral recommendation - MSN |
| 2021-05-04 | -3.0% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-02-11 | -3.0% | news | Yahoo Finance | Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers - Yahoo Finance |
| 2021-07-30 | -2.9% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2024-12-09 | +2.9% | legal | SEC EDGAR | IDXX 8-K: 8.01 and (SEC Filing) |
| 2025-09-09 | -2.8% | news | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript |
| 2025-12-23 | -2.8% | news | MarketWatch | IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch |
| 2026-04-10 | -2.7% | news | GuruFocus | IDEXX Laboratories Inc (IDXX) Stock Down 3.7% -- Now Undervalued? GF Score: 99/100 - GuruFocus |
| 2025-09-10 | -2.7% | analyst | Yahoo Finance | IDEXX Laboratories Stock: Is IDXX Outperforming the Healthcare Sector? - Yahoo Finance |
| 2025-02-14 | -2.6% | legal | SEC EDGAR | IDXX 8-K: 5.02 (SEC Filing) |
| 2025-07-25 | +2.6% | news | Yahoo Finance | IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Yahoo Finance |
| 2026-04-20 | -2.6% | news | DirectorsTalk Interviews | IDEXX Laboratories, Inc. (IDXX) Stock Analysis: A Healthcare Giant with 24% Upside Potential - DirectorsTalk Interviews |
| 2026-04-23 | -2.5% | news | MarketWatch | IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-04-23 | -2.5% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | IDXX (IDEXX Laboratories Inc.) posts Q4 2025 earnings beat and double digit revenue growth, shares drop 1.86 percent today. - Expansion Phase - Cổng thông tin điện tử tỉnh Lào Cai |
| 2025-12-03 | -2.5% | news | Yahoo Finance | How Is IDEXX Laboratories’ Stock Performance Compared to Other Health Care Stocks? - Yahoo Finance |
| 2025-07-23 | +2.5% | news | simplywall.st | At US$532, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely? - simplywall.st |
| 2026-02-23 | +2.4% | news | Finviz | Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX) - Finviz |
| 2026-02-23 | +2.4% | news | Insider Monkey | Reasons Why Hedge Funds Still Fancy IDEXX Laboratories, Inc. (IDXX) - Insider Monkey |
| 2026-03-02 | -2.4% | news | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference Prepared Remarks Transcript |
| 2026-03-02 | -2.4% | executive | TradingView | IDEXX Laboratories CEO Jonathan Jay Mazelsky Sells Over 23,000 Shares - TradingView |
| 2026-01-28 | -2.4% | earnings | Yahoo Finance | Here's How IDEXX Laboratories Is Placed Ahead of Q4 Earnings - Yahoo Finance |
| 2024-08-06 | +2.4% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-03-12 | -2.4% | news | GuruFocus | IDEXX Laboratories Inc (IDXX) Shares Down 3.75% on Mar 12 - GuruFocus |
| 2026-03-31 | -2.3% | earnings | MarketBeat | IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $675.00 at Stifel Nicolaus - MarketBeat |
| 2026-04-22 | -2.0% | earnings | Seeking Alpha | IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison |
| 2026-04-22 | -2.0% | earnings | Seeking Alpha | IDEXX Laboratories Vs. Zoetis: A Pre-Earnings Comparison (NASDAQ:IDXX) - Seeking Alpha |
| 2026-04-22 | -2.0% | earnings | MarketBeat | PFG Advisors Has $3.42 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat |
| 2026-04-22 | -2.0% | earnings | MarketBeat | Zurcher Kantonalbank Zurich Cantonalbank Purchases 11,738 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat |
| 2023-11-01 | +2.0% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2021-12-09 | -2.0% | legal | SEC EDGAR | IDXX 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-08-16 | -2.0% | earnings | simplywall.st | Earnings Not Telling The Story For IDEXX Laboratories, Inc. (NASDAQ:IDXX) After Shares Rise 25% - simplywall.st |
| 2026-03-30 | -1.9% | earnings | MarketBeat | IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc. - MarketBeat |
| 2025-12-04 | -1.9% | news | The Globe and Mail | IDEXX Laboratories Stock Rallies 75.6% YTD: What's Behind the Surge? - The Globe and Mail |
| 2023-07-12 | +1.9% | legal | SEC EDGAR | IDXX 8-K: 5.02 and (SEC Filing) |
| 2026-04-02 | +1.7% | news | Seeking Alpha | Maine governor backs millionaire tax as Senate primary tightens |
| 2025-10-02 | +1.7% | earnings | Seeking Alpha | IDEXX Laboratories: Recurring Revenue And Market Moat - Why I Choose To Buy |
| 2025-10-02 | +1.7% | earnings | Seeking Alpha | IDEXX Laboratories: Recurring Revenue And Market Moat - Why I Choose To Buy - Seeking Alpha |
| 2025-11-13 | -1.6% | legal | SEC EDGAR | IDXX 8-K: 1.01, 2.03 (SEC Filing) |
| 2026-04-13 | +1.5% | news | Yahoo Finance | IDEXX Laboratories Stock Up 39.4% in a Year: What's Driving It? - Yahoo Finance |
| 2026-04-13 | +1.5% | earnings | MarketBeat | IDEXX Laboratories, Inc. $IDXX Stock Position Lifted by Sumitomo Mitsui Trust Group Inc. - MarketBeat |
| 2026-04-13 | +1.5% | earnings | MarketBeat | IDEXX Laboratories, Inc. (NASDAQ:IDXX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat |
| 2026-04-13 | +1.5% | expansion | Sahm | The Bull Case For IDEXX Laboratories (IDXX) Could Change Following UK Launch Of Canine Cancer Dx Panel – Learn Why - Sahm |
| 2026-02-12 | -1.5% | news | Stock Titan | IDEXX execs to join BofA animal health and Raymond James investor talks - Stock Titan |
| 2024-11-12 | -1.4% | legal | SEC EDGAR | IDXX 8-K: 5.02 and (SEC Filing) |
| 2026-04-08 | -1.4% | news | Stock Titan | IDEXX will post first-quarter results May 5 before markets open - Stock Titan |
| 2026-04-08 | -1.4% | analyst | MarketWatch | IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-03-10 | -1.3% | news | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Presents at 47th Annual Raymond James Institutional Investor Conference - Slideshow |
| 2026-03-10 | -1.3% | news | Yahoo Finance | Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance |
| 2026-03-10 | -1.3% | news | TIKR.com | IDEXX Laboratories Stock: Here’s Why Wall Street Sets $750 Mean Target - TIKR.com |
| 2022-08-02 | +1.3% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-04-17 | +1.3% | analyst | MarketWatch | IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-01-13 | -1.3% | executive | Seeking Alpha | IDEXX appoints Michael Erickson as CEO |
| 2026-01-13 | -1.3% | legal | SEC EDGAR | IDXX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-13 | -1.3% | executive | Stock Titan | New leader to guide pet health innovator IDEXX as Michael Erickson becomes CEO - Stock Titan |
| 2025-07-10 | -1.3% | legal | SEC EDGAR | IDXX 8-K: 5.02 and (SEC Filing) |
| 2025-12-31 | -1.2% | news | Yahoo Finance | IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 65% return over the last year - Yahoo Finance |
| 2026-02-07 | -1.2% | news | Insider Monkey | IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey |
| 2026-02-13 | +1.2% | legal | SEC EDGAR | IDXX 8-K: 5.02 (SEC Filing) |
| 2024-11-21 | -1.2% | legal | SEC EDGAR | IDXX 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-03-14 | +1.2% | news | Yahoo Finance | Is IDEXX Laboratories, Inc. (IDXX) A Good Stock To Buy? - Yahoo Finance |
| 2026-03-14 | +1.2% | news | Insider Monkey | Is IDEXX Laboratories, Inc. (IDXX) A Good Stock To Buy? - Insider Monkey |
| 2026-04-21 | -1.2% | earnings | Barchart | What You Need to Know Ahead of IDEXX Laboratories' Earnings Release |
| 2026-03-16 | +1.0% | news | Seeking Alpha | Most oversold healthcare stocks above $10B on Wall Street amid Middle East disruptions |
| 2026-03-16 | +1.0% | analyst | Yahoo Finance | Is IDEXX Laboratories Stock Outperforming the S&P 500? - Yahoo Finance |
| 2026-01-21 | -0.9% | news | Yahoo Finance | Is IDEXX Laboratories Stock the Right Pick for Your Portfolio Now? - Yahoo Finance |
| 2026-02-26 | +0.9% | legal | Seeking Alpha | IDEXX Laboratories, Inc. (IDXX) Presents at BofA Securities Animal Health Summit Transcript |
| 2026-03-06 | -0.9% | news | TradingView | Is This the Right Time to Retain IDXX Stock in Your Portfolio? - TradingView |
| 2026-01-09 | +0.9% | news | Investor's Business Daily | Stock Of The Day Idexx Praised As 'Dognostics' Leader - Investor's Business Daily |
| 2026-01-09 | +0.9% | news | Stock Titan | Pet healthcare leader IDEXX shares 2025 results on Feb. 2 - Stock Titan |
| 2026-04-03 | +0.9% | news | Yahoo Finance | Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance |
| 2026-02-20 | -0.9% | analyst | Yahoo Finance | Here’s Why IDEXX Laboratories (IDXX) Shares are Re-Rating to Historical Average - Yahoo Finance |
| 2026-04-19 | -0.9% | earnings | MarketBeat | Ninety One UK Ltd Decreases Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat |
| 2026-04-18 | -0.9% | news | Simply Wall St. | Is It Too Late To Consider IDEXX Laboratories (IDXX) After A 43% One Year Rally? |
| 2026-04-18 | -0.9% | earnings | MarketBeat | Mirae Asset Global Investments Co. Ltd. Purchases 6,572 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat |
| 2026-04-14 | -0.8% | news | Zacks | Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now? |
| 2026-04-14 | -0.8% | analyst | MT Newswires | Leerink Partners Adjusts IDEXX Laboratories PT to $725 From $760, Maintains Outperform Rating |
| 2026-04-14 | -0.8% | news | TradingView | Is it a Prudent Move to Retain IDXX Stock in Your Portfolio Now? - TradingView |
| 2026-04-14 | -0.8% | analyst | MarketWatch | IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-04-14 | -0.8% | earnings | MarketBeat | Third View Private Wealth LLC Invests $1.21 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat |
| 2026-03-22 | -0.8% | news | TIKR.com | IDEXX Stock Fell 14% in 2026. Here’s Why $750 Target Mean Still Holds - TIKR.com |
| 2024-11-06 | +0.8% | legal | SEC EDGAR | IDXX 8-K: 1.01 (SEC Filing) |
| 2025-10-09 | +0.8% | news | Yahoo Finance | Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo Finance |
| 2025-10-09 | +0.8% | executive | Quiver Quantitative | IDEXX Laboratories Stock (IDXX) Opinions on Recent Board Appointment - Quiver Quantitative |
| 2025-10-09 | +0.8% | earnings | Yahoo Finance | Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again - Yahoo Finance |
| 2026-03-27 | -0.8% | news | MarketWatch | IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch |
| 2026-03-27 | -0.8% | legal | Stock Titan | [ARS] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan |
| 2025-12-18 | -0.7% | news | Stock Traders Daily | How Idexx Laboratories Inc. (IDXX) Affects Rotational Strategy Timing - Stock Traders Daily |
| 2023-12-07 | +0.7% | legal | SEC EDGAR | IDXX 8-K: 5.02 (SEC Filing) |
| 2026-02-15 | -0.7% | analyst | Yahoo Finance | IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets - Yahoo Finance |
| 2025-11-06 | -0.7% | news | Yahoo Finance | Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Yahoo Finance |
| 2024-12-12 | -0.6% | legal | SEC EDGAR | IDXX 8-K: 5.02 (SEC Filing) |
| 2026-04-01 | +0.5% | news | Stock Titan | Dog cancer test reaches UK, with signals found up to 8 months early - Stock Titan |
| 2025-11-04 | +0.5% | news | Seeking Alpha | IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects |
| 2022-10-21 | +0.5% | legal | SEC EDGAR | IDXX 8-K: 1.01, 2.03 (SEC Filing) |
| 2025-09-01 | -0.4% | news | Seeking Alpha | SA Graphics: Here are the biggest S&P 500 gainers and losers in August |
| 2026-03-26 | +0.4% | legal | SEC EDGAR | IDXX 8-K: 5.02 and (SEC Filing) |
| 2026-03-26 | +0.4% | news | Stock Titan | IDEXX Laboratories (NASDAQ: IDXX) executive Nimrata Hunt plans exit with package - Stock Titan |
| 2025-12-29 | -0.4% | news | Yahoo Finance | Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance |
| 2026-04-06 | +0.4% | earnings | MarketBeat | IDEXX Laboratories, Inc. $IDXX Shares Sold by Rathbones Group PLC - MarketBeat |
| 2026-04-06 | +0.4% | analyst | MarketWatch | IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch |
| 2026-04-06 | +0.4% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Is IDEXX Laboratories (IDXX) Stock Trading at Fair Value | Price at $577.44, Up 1.39% - Expert Verified Trades - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-05-02 | -0.4% | legal | SEC EDGAR | IDXX 8-K: 2.02 and (SEC Filing) |
| 2026-02-05 | -0.4% | news | Yahoo Finance | Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability - Yahoo Finance |
| 2026-02-05 | -0.4% | news | Yahoo Finance | IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market - Yahoo Finance |
| 2026-02-19 | -0.3% | executive | TIKR.com | IDEXX Stock Has Rallied 40% Over the Past Year: Can a New CEO Keep the Momentum Going? - TIKR.com |
| 2024-05-10 | +0.3% | legal | SEC EDGAR | IDXX 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-10-07 | +0.1% | legal | SEC EDGAR | IDXX 8-K: 5.02 and (SEC Filing) |
| 2025-10-07 | +0.1% | news | Gotrade | IDEXX Labs (IDXX) Stock Price Today & Analysis - Gotrade |
| 2026-04-07 | -0.1% | analyst | TIKR.com | Here’s Why Analysts Have IDEXX Stock Priced at $742 - TIKR.com |
| 2026-04-07 | -0.1% | analyst | The Globe and Mail | Analysts Offer Insights on Healthcare Companies: aTyr Pharma (ATYR) and Idexx Laboratories (IDXX) - The Globe and Mail |
| 2026-04-16 | +0.0% | news | Zacks | Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term |
| 2026-04-16 | +0.0% | news | Yahoo Finance | Why Idexx Laboratories (IDXX) is a Top Momentum Stock for the Long-Term - Yahoo Finance |
| 2026-04-16 | +0.0% | news | MarketWatch | IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors - MarketWatch |
| 2026-04-24 | — | earnings | Zacks | Will DXCM's G7 Uptake Continue to Drive Top-line Growth in Q1? |
| 2026-04-24 | — | news | TIKR.com | Why IDEXX Laboratories Stock Is Undervalued at $561 in 2026 - TIKR.com |
| 2026-04-24 | — | news | GuruFocus | IDEXX Laboratories Inc (IDXX) Shares Fall 3.0% -- What GF Score of 99 Tells Investors - GuruFocus |